Role	role	O	O	O	O
of	of	O	O	O	O
activation	activation	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
B2	b2	O	O	O	O
receptors	receptors	O	O	O	O
in	in	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
during	during	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Cellular	cellular	O	O	O	O
mechanisms	mechanisms	O	O	O	O
which	which	O	O	O	O
account	account	O	O	O	O
for	for	O	O	O	O
disruption	disruption	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
during	during	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
are	are	O	O	O	O
not	not	O	O	O	O
clear	clear	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
goal	goal	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
determine	determine	O	O	O	O
the	the	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
synthesis/release	synthesis/release	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
activate	activate	O	O	O	O
B2	b2	O	O	O	O
receptors	receptors	O	O	O	O
in	in	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
during	during	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Permeability	permeability	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
was	was	O	O	O	O
quantitated	quantitated	O	O	O	O
by	by	O	O	O	O
clearance	clearance	O	O	O	O
of	of	O	O	O	O
fluorescent-labeled	fluorescent-labeled	O	O	O	O
dextran	dextran	CHEMICALS	O	OTHERS	I
before	before	O	O	O	O
and	and	O	O	O	O
during	during	O	O	O	O
phenylephrine-induced	phenylephrine-induced	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
vehicle	vehicle	O	O	O	O
and	and	O	O	O	O
Hoe-140	hoe-140	O	O	OTHERS	I
(	(	O	O	O	O
0.1	0.1	O	O	O	O
microM	microm	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
increased	increased	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
arteriolar	arteriolar	O	O	O	O
diameter	diameter	O	O	O	O
and	and	O	O	O	O
clearance	clearance	O	O	O	O
of	of	O	O	O	O
fluorescent	fluorescent	O	O	O	O
dextran	dextran	CHEMICALS	O	OTHERS	I
by	by	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
magnitude	magnitude	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
findings	findings	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
during	during	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
synthesis/release	synthesis/release	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
activate	activate	O	O	O	O
B2	b2	O	O	O	O
receptors	receptors	O	O	O	O
.	.	O	O	O	O

